We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KSU
301
DELISTED
Kansas City Southern
KSU
$553K ﹤0.01%
3,613
– –
GSK icon
302
GSK
GSK
$104B
$551K ﹤0.01%
9,384
+255
+3% +$14.2K
IFF icon
303
International Flavors & Fragrances
IFF
$21.6B
$538K ﹤0.01%
4,167
– –
HOFT icon
304
Hooker Furnishings Corp
HOFT
$163M
$531K ﹤0.01%
20,687
-522
-2% -$12.3K
DHR icon
305
Danaher
DHR
$141B
$523K ﹤0.01%
3,845
-6,788
-64% -$858K
HRL icon
306
Hormel Foods
HRL
$13.8B
$496K ﹤0.01%
11,000
– –
HDB icon
307
HDFC Bank
HDB
$122B
$441K ﹤0.01%
13,920
-2,000
-13% -$60.9K
CI icon
308
Cigna
CI
$72.7B
$434K ﹤0.01%
2,120
-316
-13% -$57.9K
HPE icon
309
Hewlett Packard
HPE
$69.4B
$429K ﹤0.01%
27,069
– –
DD icon
310
DuPont de Nemours
DD
$19.5B
$428K ﹤0.01%
5,310
-241
-4% -$20K
COP icon
311
ConocoPhillips
COP
$140B
$414K ﹤0.01%
6,372
+192
+3% +$11.3K
CVS icon
312
CVS Health
CVS
$123B
$402K ﹤0.01%
5,409
-788
-13% -$55.3K
CFR icon
313
Cullen/Frost Bankers
CFR
$10.2B
$391K ﹤0.01%
4,000
– –
SCHW
314
Charles Schwab
SCHW
$187B
$391K ﹤0.01%
8,226
+15
+0.2% +$661
BA icon
315
Boeing
BA
$184B
$383K ﹤0.01%
1,175
-18,261
-94% -$6.46M
GILD icon
316
Gilead Sciences
GILD
$162B
$379K ﹤0.01%
5,835
-51
-0.9% -$3.32K
ATVI
317
DELISTED
Activision Blizzard
ATVI
$371K ﹤0.01%
6,245
– –
VXUS icon
318
Vanguard Total International Stock ETF
VXUS
$158B
$369K ﹤0.01%
+6,625
New +$356K
BIP icon
319
Brookfield Infrastructure Partners
BIP
$17.9B
$345K ﹤0.01%
11,592
– –
AXP icon
320
American Express
AXP
$231B
$336K ﹤0.01%
2,701
+855
+46% +$102K
MPC icon
321
Marathon Petroleum
MPC
$84B
$324K ﹤0.01%
5,379
+378
+8% +$23.6K
CMI icon
322
Cummins
CMI
$88.7B
$319K ﹤0.01%
1,782
-219
-11% -$38.5K
DLTR icon
323
Dollar Tree
DLTR
$24.9B
$317K ﹤0.01%
+3,370
New +$354K
WELL icon
324
Welltower
WELL
$170B
$317K ﹤0.01%
3,881
– –
PYPL icon
325
PayPal
PYPL
$51.1B
$316K ﹤0.01%
2,917
+237
+9% +$24.7K
11 12
13
14 15

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.